Cahaba Pharmaceuticals
Princeton, US · Founded 2008
Biotech
Founders & leadership
JR
J. Rainer TwifordNamed on SEC filing
AP
Andrew P. AromandoNamed on SEC filing
MK
Madding King, IIINamed on SEC filing
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2012
▶$250KraisedMar 2012 · 1 investors · PharmaceuticalsRule 506(b)
▶$250KraisedMar 2012 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- J. Rainer TwifordExecutive Officer, Director
- Andrew P. AromandoExecutive Officer
- Madding King, IIIExecutive Officer, Director
- Amount sold
- $250K
- Sales commissions
- $7.5K
- Placement agents
- Gottbetter Capital Markets, LLC
- First sale
- Mar 2012
- Incorporated
- Limited Liability Company, Delaware, 2008
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Cahaba Pharmaceuticals raised?
- Cahaba Pharmaceuticals has disclosed $250K raised across 1 round.
- Where is Cahaba Pharmaceuticals headquartered?
- Cahaba Pharmaceuticals is headquartered in Princeton, US.